Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T81735
|
||||
Former ID |
TTDR01142
|
||||
Target Name |
DNA-dependent protein kinase catalytic subunit
|
||||
Gene Name |
PRKDC
|
||||
Synonyms |
DNA-PK; DNA-PKcs; DNA-dependent protein kinase; DNPK1; P460; PRKDC
|
||||
Target Type |
Research
|
||||
Disease | Cancer [ICD9: 140-229; ICD10: C00-C96] | ||||
Prostate cancer [ICD9: 185; ICD10: C61] | |||||
Function |
Ser/thr kinase involved in dna double-stranded break repair, v(d)j recombination and modulation of transcription. Must be bound to dna to express its catalytic properties.
|
||||
BioChemical Class |
Kinase
|
||||
Target Validation |
T81735
|
||||
UniProt ID | |||||
EC Number |
EC 2.7.11.1
|
||||
Sequence |
MAGSGAGVRCSLLRLQETLSAADRCGAALAGHQLIRGLGQECVLSSSPAVLALQTSLVFS
RDFGLLVFVRKSLNSIEFRECREEILKFLCIFLEKMGQKIAPYSVEIKNTCTSVYTKDRA AKCKIPALDLLIKLLQTFRSSRLMDEFKIGELFSKFYGELALKKKIPDTVLEKVYELLGL LGEVHPSEMINNAENLFRAFLGELKTQMTSAVREPKLPVLAGCLKGLSSLLCNFTKSMEE DPQTSREIFNFVLKAIRPQIDLKRYAVPSAGLRLFALHASQFSTCLLDNYVSLFEVLLKW CAHTNVELKKAALSALESFLKQVSNMVAKNAEMHKNKLQYFMEQFYGIIRNVDSNNKELS IAIRGYGLFAGPCKVINAKDVDFMYVELIQRCKQMFLTQTDTGDDRVYQMPSFLQSVASV LLYLDTVPEVYTPVLEHLVVMQIDSFPQYSPKMQLVCCRAIVKVFLALAAKGPVLRNCIS TVVHQGLIRICSKPVVLPKGPESESEDHRASGEVRTGKWKVPTYKDYVDLFRHLLSSDQM MDSILADEAFFSVNSSSESLNHLLYDEFVKSVLKIVEKLDLTLEIQTVGEQENGDEAPGV WMIPTSDPAANLHPAKPKDFSAFINLVEFCREILPEKQAEFFEPWVYSFSYELILQSTRL PLISGFYKLLSITVRNAKKIKYFEGVSPKSLKHSPEDPEKYSCFALFVKFGKEVAVKMKQ YKDELLASCLTFLLSLPHNIIELDVRAYVPALQMAFKLGLSYTPLAEVGLNALEEWSIYI DRHVMQPYYKDILPCLDGYLKTSALSDETKNNWEVSALSRAAQKGFNKVVLKHLKKTKNL SSNEAISLEEIRIRVVQMLGSLGGQINKNLLTVTSSDEMMKSYVAWDREKRLSFAVPFRE MKPVIFLDVFLPRVTELALTASDRQTKVAACELLHSMVMFMLGKATQMPEGGQGAPPMYQ LYKRTFPVLLRLACDVDQVTRQLYEPLVMQLIHWFTNNKKFESQDTVALLEAILDGIVDP VDSTLRDFCGRCIREFLKWSIKQITPQQQEKSPVNTKSLFKRLYSLALHPNAFKRLGASL AFNNIYREFREEESLVEQFVFEALVIYMESLALAHADEKSLGTIQQCCDAIDHLCRIIEK KHVSLNKAKKRRLPRGFPPSASLCLLDLVKWLLAHCGRPQTECRHKSIELFYKFVPLLPG NRSPNLWLKDVLKEEGVSFLINTFEGGGCGQPSGILAQPTLLYLRGPFSLQATLCWLDLL LAALECYNTFIGERTVGALQVLGTEAQSSLLKAVAFFLESIAMHDIIAAEKCFGTGAAGN RTSPQEGERYNYSKCTVVVRIMEFTTTLLNTSPEGWKLLKKDLCNTHLMRVLVQTLCEPA SIGFNIGDVQVMAHLPDVCVNLMKALKMSPYKDILETHLREKITAQSIEELCAVNLYGPD AQVDRSRLAAVVSACKQLHRAGLLHNILPSQSTDLHHSVGTELLSLVYKGIAPGDERQCL PSLDLSCKQLASGLLELAFAFGGLCERLVSLLLNPAVLSTASLGSSQGSVIHFSHGEYFY SLFSETINTELLKNLDLAVLELMQSSVDNTKMVSAVLNGMLDQSFRERANQKHQGLKLAT TILQHWKKCDSWWAKDSPLETKMAVLALLAKILQIDSSVSFNTSHGSFPEVFTTYISLLA DTKLDLHLKGQAVTLLPFFTSLTGGSLEELRRVLEQLIVAHFPMQSREFPPGTPRFNNYV DCMKKFLDALELSQSPMLLELMTEVLCREQQHVMEELFQSSFRRIARRGSCVTQVGLLES VYEMFRKDDPRLSFTRQSFVDRSLLTLLWHCSLDALREFFSTIVVDAIDVLKSRFTKLNE STFDTQITKKMGYYKILDVMYSRLPKDDVHAKESKINQVFHGSCITEGNELTKTLIKLCY DAFTENMAGENQLLERRRLYHCAAYNCAISVICCVFNELKFYQGFLFSEKPEKNLLIFEN LIDLKRRYNFPVEVEVPMERKKKYIEIRKEAREAANGDSDGPSYMSSLSYLADSTLSEEM SQFDFSTGVQSYSYSSQDPRPATGRFRRREQRDPTVHDDVLELEMDELNRHECMAPLTAL VKHMHRSLGPPQGEEDSVPRDLPSWMKFLHGKLGNPIVPLNIRLFLAKLVINTEEVFRPY AKHWLSPLLQLAASENNGGEGIHYMVVEIVATILSWTGLATPTGVPKDEVLANRLLNFLM KHVFHPKRAVFRHNLEIIKTLVECWKDCLSIPYRLIFEKFSGKDPNSKDNSVGIQLLGIV MANDLPPYDPQCGIQSSEYFQALVNNMSFVRYKEVYAAAAEVLGLILRYVMERKNILEES LCELVAKQLKQHQNTMEDKFIVCLNKVTKSFPPLADRFMNAVFFLLPKFHGVLKTLCLEV VLCRVEGMTELYFQLKSKDFVQVMRHRDDERQKVCLDIIYKMMPKLKPVELRELLNPVVE FVSHPSTTCREQMYNILMWIHDNYRDPESETDNDSQEIFKLAKDVLIQGLIDENPGLQLI IRNFWSHETRLPSNTLDRLLALNSLYSPKIEVHFLSLATNFLLEMTSMSPDYPNPMFEHP LSECEFQEYTIDSDWRFRSTVLTPMFVETQASQGTLQTRTQEGSLSARWPVAGQIRATQQ QHDFTLTQTADGRSSFDWLTGSSTDPLVDHTSPSSDSLLFAHKRSERLQRAPLKSVGPDF GKKRLGLPGDEVDNKVKGAAGRTDLLRLRRRFMRDQEKLSLMYARKGVAEQKREKEIKSE LKMKQDAQVVLYRSYRHGDLPDIQIKHSSLITPLQAVAQRDPIIAKQLFSSLFSGILKEM DKFKTLSEKNNITQKLLQDFNRFLNTTFSFFPPFVSCIQDISCQHAALLSLDPAAVSAGC LASLQQPVGIRLLEEALLRLLPAELPAKRVRGKARLPPDVLRWVELAKLYRSIGEYDVLR GIFTSEIGTKQITQSALLAEARSDYSEAAKQYDEALNKQDWVDGEPTEAEKDFWELASLD CYNHLAEWKSLEYCSTASIDSENPPDLNKIWSEPFYQETYLPYMIRSKLKLLLQGEADQS LLTFIDKAMHGELQKAILELHYSQELSLLYLLQDDVDRAKYYIQNGIQSFMQNYSSIDVL LHQSRLTKLQSVQALTEIQEFISFISKQGNLSSQVPLKRLLNTWTNRYPDAKMDPMNIWD DIITNRCFFLSKIEEKLTPLPEDNSMNVDQDGDPSDRMEVQEQEEDISSLIRSCKFSMKM KMIDSARKQNNFSLAMKLLKELHKESKTRDDWLVSWVQSYCRLSHCRSRSQGCSEQVLTV LKTVSLLDENNVSSYLSKNILAFRDQNILLGTTYRIIANALSSEPACLAEIEEDKARRIL ELSGSSSEDSEKVIAGLYQRAFQHLSEAVQAAEEEAQPPSWSCGPAAGVIDAYMTLADFC DQQLRKEEENASVIDSAELQAYPALVVEKMLKALKLNSNEARLKFPRLLQIIERYPEETL SLMTKEISSVPCWQFISWISHMVALLDKDQAVAVQHSVEEITDNYPQAIVYPFIISSESY SFKDTSTGHKNKEFVARIKSKLDQGGVIQDFINALDQLSNPELLFKDWSNDVRAELAKTP VNKKNIEKMYERMYAALGDPKAPGLGAFRRKFIQTFGKEFDKHFGKGGSKLLRMKLSDFN DITNMLLLKMNKDSKPPGNLKECSPWMSDFKVEFLRNELEIPGQYDGRGKPLPEYHVRIA GFDERVTVMASLRRPKRIIIRGHDEREHPFLVKGGEDLRQDQRVEQLFQVMNGILAQDSA CSQRALQLRTYSVVPMTSRLGLIEWLENTVTLKDLLLNTMSQEEKAAYLSDPRAPPCEYK DWLTKMSGKHDVGAYMLMYKGANRTETVTSFRKRESKVPADLLKRAFVRMSTSPEAFLAL RSHFASSHALICISHWILGIGDRHLNNFMVAMETGGVIGIDFGHAFGSATQFLPVPELMP FRLTRQFINLMLPMKETGLMYSIMVHALRAFRSDPGLLTNTMDVFVKEPSFDWKNFEQKM LKKGGSWIQEINVAEKNWYPRQKICYAKRKLAGANPAVITCDELLLGHEKAPAFRDYVAV ARGSKDHNIRAQEPESGLSEETQVKCLMDQATDPNILGRTWEGWEPWM |
||||
Inhibitor | 1-Morpholin-4-yl-benzo[f]chromen-3-one | Drug Info | [527386] | ||
2-(1H-indol-5-yl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(2-aminophenyl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(2-Fluoro-phenyl)-benzo[h]chromen-4-one | Drug Info | [527386] | |||
2-(2-methoxyphenyl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one | Drug Info | [527296] | |||
2-(3-acetylphenyl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(3-Fluoro-phenyl)-benzo[h]chromen-4-one | Drug Info | [527386] | |||
2-(3-methoxyphenyl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(4-Amino-phenyl)-benzo[h]chromen-4-one | Drug Info | [527386] | |||
2-(4-chlorophenyl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(4-fluorophenyl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(4-methoxyphenyl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(benzofuran-2-yl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(furan-2-yl)-6-morpholino-4H-pyran-4-one | Drug Info | [528738] | |||
2-(piperidin-1-yl)-4H-benzo[h]chromen-4-one | Drug Info | [527888] | |||
2-biphenyl-4-yl-6-morpholin-4-yl-pyran-4-one | Drug Info | [528738] | |||
2-dibenzofuran-4-yl-6-morpholin-4-yl-pyran-4-one | Drug Info | [528738] | |||
2-morpholin-4-yl-6-phenyl-4H-thiopyran-4-one | Drug Info | [528738] | |||
2-Morpholin-4-yl-6-phenyl-chromen-4-one | Drug Info | [527386] | |||
2-morpholin-4-yl-8-naphthalen-2-ylchromen-4-one | Drug Info | [527888] | |||
2-morpholin-4-yl-8-phenoxathiin-4-ylchromen-4-one | Drug Info | [527888] | |||
2-morpholin-4-yl-8-styrylchromen-4-one | Drug Info | [527888] | |||
2-morpholin-4-yl-8-thiophen-2-ylchromen-4-one | Drug Info | [527888] | |||
2-morpholin-4-yl-8-thiophen-3-ylchromen-4-one | Drug Info | [527888] | |||
2-Morpholin-4-yl-benzo[h]chromene-4-thione | Drug Info | [527386] | |||
2-Morpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one | Drug Info | [527386] | |||
2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one | Drug Info | [527386] | |||
2-morpholino-4H-benzo[g]chromen-4-one | Drug Info | [527888] | |||
2-morpholino-6-(naphthalen-1-yl)-4H-chromen-4-one | Drug Info | [527888] | |||
2-morpholino-6-(naphthalen-1-yl)-4H-pyran-4-one | Drug Info | [528738] | |||
2-morpholino-6-(naphthalen-2-yl)-4H-pyran-4-one | Drug Info | [528738] | |||
2-morpholino-6-(quinolin-8-yl)-4H-pyran-4-one | Drug Info | [528738] | |||
2-morpholino-6-(thianthren-1-yl)-4H-chromen-4-one | Drug Info | [527888] | |||
2-morpholino-6-(thiophen-2-yl)-4H-pyran-4-one | Drug Info | [528738] | |||
2-morpholino-6-(thiophen-3-yl)-4H-pyran-4-one | Drug Info | [528738] | |||
2-morpholino-6-phenyl-4H-pyran-4-one | Drug Info | [528738] | |||
2-morpholino-6-styryl-4H-pyran-4-one | Drug Info | [528738] | |||
2-morpholinobenzo[h]quinolin-4(1H)-one | Drug Info | [527888] | |||
2-Pyridin-3-yl-benzo[h]chromen-4-one | Drug Info | [527386] | |||
2-Pyrrolidin-1-yl-benzo[h]chromen-4-one | Drug Info | [527386] | |||
2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one | Drug Info | [527386] | |||
2-thiomorpholino-4H-benzo[h]chromen-4-one | Drug Info | [527888] | |||
2-[1,4]Oxazepan-4-yl-benzo[h]chromen-4-one | Drug Info | [527386] | |||
3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzaldehyde | Drug Info | [528738] | |||
3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzoic acid | Drug Info | [528738] | |||
3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile | Drug Info | [528738] | |||
3-morpholino-1H-benzo[f]chromen-1-one | Drug Info | [528738] | |||
4-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile | Drug Info | [528738] | |||
4-Morpholin-4-yl-benzo[g]chromen-2-one | Drug Info | [527386] | |||
4-Morpholin-4-yl-benzo[h]chromen-2-one | Drug Info | [527386] | |||
4-Morpholin-4-yl-chromen-2-one | Drug Info | [527386] | |||
4-morpholino-6-phenyl-2H-pyran-2-one | Drug Info | [528738] | |||
4-Piperidin-1-yl-chromen-2-one | Drug Info | [527386] | |||
4-Thiomorpholin-4-yl-benzo[g]chromen-2-one | Drug Info | [527386] | |||
6-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
6-(3-hydroxyphenyl)-2-morpholino-4H-chromen-4-one | Drug Info | [527888] | |||
6-(4-chlorophenyl)-2-morpholin-4-ylpyridin-4-ol | Drug Info | [528738] | |||
6-(4-chlorophenyl)-4-morpholino-2H-pyran-2-one | Drug Info | [528738] | |||
6-(4-fluorostyryl)-2-morpholino-4H-chromen-4-one | Drug Info | [527888] | |||
6-(4-hydroxyphenyl)-2-morpholino-4H-chromen-4-one | Drug Info | [527888] | |||
6-(4-methoxyphenyl)-4-morpholino-2H-pyran-2-one | Drug Info | [528738] | |||
6-biphenyl-2-yl-2-morpholin-4-yl-chromen-4-one | Drug Info | [527888] | |||
6-Chloro-4-morpholin-4-yl-chromen-2-one | Drug Info | [527386] | |||
6-isopropyl-2-morpholin-4-yl-4H-thiopyran-4-one | Drug Info | [528738] | |||
6-Methoxy-4-morpholin-4-yl-chromen-2-one | Drug Info | [527386] | |||
6-Methyl-4-morpholin-4-yl-chromen-2-one | Drug Info | [527386] | |||
6-tert-Butyl-2-morpholin-4-yl-4H-thiopyran-4-one | Drug Info | [528738] | |||
7-benzoyloxy-2-(morpholin-4-yl)-chromen-4-one | Drug Info | [527888] | |||
7-benzyloxy-2-(morpholin-4-yl)-chromen-4-one | Drug Info | [527888] | |||
7-ethyloxyethoxy-2-morpholin-4-yl-chromen-4-one | Drug Info | [527888] | |||
7-hydroxy-2-(morpholin-4-yl)chromen-4-one | Drug Info | [527888] | |||
7-Methoxy-2-morpholin-4-yl-chromen-4-one | Drug Info | [527386] | |||
7-Methoxy-4-morpholin-4-yl-chromen-2-one | Drug Info | [527386] | |||
7-phenylethoxy-2-morpholin-4-yl-chromen-4-one | Drug Info | [527888] | |||
7-phenyloxyethoxy-2-morpholin-4-yl-chromen-4-one | Drug Info | [527888] | |||
7-propoxy-2-(morpholin-4-yl)-chromen-4-one | Drug Info | [527888] | |||
8-(1H-indol-5-yl)-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-(3-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-(4-acetylphenyl)-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-(4-chlorophenyl)-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-(4-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-biphenyl-2-yl-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-dibenzofuran-4-yl-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-furan-2-yl-2-morpholin-4-ylchromen-4-one | Drug Info | [527888] | |||
8-Methoxy-2-morpholin-4-yl-chromen-4-one | Drug Info | [527386] | |||
8-Methoxy-4-morpholin-4-yl-chromen-2-one | Drug Info | [527386] | |||
8-Methyl-2-morpholin-4-yl-chromen-4-one | Drug Info | [527386] | |||
8-Methyl-4-morpholin-4-yl-chromen-2-one | Drug Info | [527386] | |||
8-Phenyl-2-piperidin-1-yl-chromen-4-one | Drug Info | [527386] | |||
8-Phenyl-2-thiomorpholin-4-yl-chromen-4-one | Drug Info | [527386] | |||
ALPHA-NAPHTHOFLAVONE | Drug Info | [527386] | |||
AMA37 | Drug Info | [528888] | |||
IC86621 | Drug Info | [531979] | |||
KU-0060648 | Drug Info | [532428] | |||
KU-55933 | Drug Info | [528738] | |||
LY-292223 | Drug Info | [527296] | |||
LY-293646 | Drug Info | [527888] | |||
NU-7432 | Drug Info | [527888] | |||
PIK-75 | Drug Info | [528169] | |||
PP121 | Drug Info | [529744] | |||
Pathways | |||||
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Pathway Interaction Database | DNA-PK pathway in nonhomologous end joining | ||||
Coregulation of Androgen receptor activity | |||||
Class I PI3K signaling events mediated by Akt | |||||
BARD1 signaling events | |||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
WikiPathways | DNA Damage Response | ||||
Non-homologous end joining | |||||
FAS pathway and Stress induction of HSP regulation | |||||
Cytosolic sensors of pathogen-associated DNA | |||||
Retinoblastoma (RB) in Cancer | |||||
Prostate Cancer | |||||
Double-Strand Break Repair | |||||
Cell Cycle | |||||
miRNA Regulation of DNA Damage Response | |||||
References | |||||
Ref 527296 | Bioorg Med Chem Lett. 2004 Dec 20;14(24):6083-7.Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. | ||||
Ref 527386 | J Med Chem. 2005 Jan 27;48(2):569-85.Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro. | ||||
Ref 527888 | J Med Chem. 2005 Dec 1;48(24):7829-46.Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. | ||||
Ref 528169 | A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006 May 19;125(4):733-47. Epub 2006 Apr 27. | ||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
Ref 528888 | Inhibition of mammalian target of rapamycin signaling by 2-(morpholin-1-yl)pyrimido[2,1-alpha]isoquinolin-4-one. J Biol Chem. 2007 Aug 17;282(33):24463-70. Epub 2007 Jun 11. | ||||
Ref 529744 | Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol. 2008 Nov;4(11):691-9. | ||||
Ref 531979 | Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family. Bioorg Med Chem Lett. 2012 Sep 1;22(17):5352-9. | ||||
Ref 532428 | 1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity. J Med Chem. 2013 Aug 22;56(16):6386-401. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.